Literature DB >> 55420

A method for the differential determination of plasma antithrombins.

V Musumeci, A Vincenti, B Bizzi.   

Abstract

A method for the differential determination of plasma antithrombins, antithrombin III and alpha2 macroglobulin, is described. The method is based on the selective inactivation of plasma alpha2 macroglobulin by treatment with 0-1 M methylamine for 10 minutes at 37 degrees C and on the observation that antithrombin III and alpha2 macroglobulin inhibited in defibrinated plasma low concentrations of thrombin without mutual interference and according to pseudo-first order reaction. In healthy subjects antithrombin III was shown to account for about 70% of the total antithrombin activity. But in patients with liver cirrhosis, where low levels of total antithrombin activity were observed, the relative contribution of antithrombin III was found to be noticeably lower.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 55420      PMCID: PMC475948          DOI: 10.1136/jcp.29.1.63

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Studies on the antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminum hydroxide.

Authors:  F C MONKHOUSE; E S FRANCE; W H SEEGERS
Journal:  Circ Res       Date:  1955-07       Impact factor: 17.367

2.  Alpha-1-antitrypsin, an inhibitor for thrombin and plasmin.

Authors:  H Gans; B H Tan
Journal:  Clin Chim Acta       Date:  1967-07       Impact factor: 3.786

3.  Dissociation of esterolytic and clotting activities of thrombin by trypsin-binding macroglobulin.

Authors:  G F Lanchantin; M L Plesset; J A Friedmann; D W Hart
Journal:  Proc Soc Exp Biol Med       Date:  1966-02

4.  The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin.

Authors:  A Rimon; Y Shamash; B Shapiro
Journal:  J Biol Chem       Date:  1966-11-10       Impact factor: 5.157

5.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

6.  [Antiproteinase activity of alpha-2-macroglobulin. II. Its role in progressive antithrombin states].

Authors:  M Steinbuch; C H Blatrix; F Josso
Journal:  Rev Fr Etud Clin Biol       Date:  1968-02

7.  Binding of thrombin to antithrombin III.

Authors:  U Abildgaard
Journal:  Scand J Clin Lab Invest       Date:  1969-08       Impact factor: 1.713

8.  Antithrombin 3, antifactor Xa and heparin.

Authors:  R Biggs; K W Denson; N Akman; R Borrett; M Hadden
Journal:  Br J Haematol       Date:  1970-09       Impact factor: 6.998

9.  Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma.

Authors:  U Abildgaard; M K Fagerhol; O Egeberg
Journal:  Scand J Clin Lab Invest       Date:  1970-12       Impact factor: 1.713

10.  Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration.

Authors:  M K Fagerhol; U Abildgaard
Journal:  Scand J Haematol       Date:  1970
View more
  2 in total

1.  α-1-antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease.

Authors:  Nicola J Sinden; Michael J Baker; David J Smith; Jan-Ulrich Kreft; Timothy R Dafforn; Robert A Stockley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-15       Impact factor: 5.464

2.  The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote.

Authors:  Nicola Jane Sinden; Firas Koura; Robert Andrew Stockley
Journal:  BMC Pulm Med       Date:  2014-08-07       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.